本文選題：新基因HA117 + cDNA克隆��； 參考：《重慶醫(yī)科大學(xué)》2008年博士論文

【摘要】： 目的 應(yīng)用組織芯片結(jié)合原位雜交的方法篩選出HA117基因組織表達(dá)譜。然后以組織表達(dá)譜篩選出的高表達(dá)HA117基因的腎臟組織為模板,通過RACE的方法克隆基因全長cDNA,進(jìn)一步應(yīng)用重組腺病毒介導(dǎo)的方法獲得高表達(dá)HA117基因的K562、Jurkat細(xì)胞,初步研究HA117基因?qū)562、Jurkat細(xì)胞的多藥耐藥(MDR)功能。 方法 1組織表達(dá)譜篩選,選取石蠟包埋的31例常見腫瘤組織標(biāo)本制和17例癌旁正常組織制作組織芯片,應(yīng)用mRNA原位雜交技術(shù)檢測HA117 mRNA在組織芯片各種組織中的表達(dá)情況; 2組織表達(dá)譜結(jié)果提示腎臟組織高表達(dá)HA117基因,收集并提取腎臟組織總mRNA,首先應(yīng)用RT-PCR方法驗(yàn)證HA117基因在腎臟組織表達(dá)情況;然后在高表達(dá)HA117基因腎臟組織中,根據(jù)已獲得的已知HA117基因序列為模板設(shè)計(jì)特異引物,通過RACE技術(shù)克隆HA117基因全長cDNA序列; 3構(gòu)建攜帶新基因HA117全長cDNA序列的重組腺病毒,酶切質(zhì)粒載體pAdTrack-CMV和目的基因HA117后,用T4DNA連接酶將載體和目的基因定向克隆連接,然后篩選和鑒定含目的基因HA117的重組質(zhì)粒pAdTrack- HA117。將篩選正確的質(zhì)粒pAdTrack- HA117導(dǎo)入已制備的腺病毒同源骨架質(zhì)粒BJ-Adeasy中,產(chǎn)生腺病毒質(zhì)粒Adeasy- HA117,進(jìn)一步酶切鑒定得到的重組腺病毒質(zhì)粒Adeasy- HA117。脂質(zhì)體介導(dǎo)的方法將Adeasy- HA117轉(zhuǎn)染入產(chǎn)病毒包裝細(xì)胞HEK 293,通過乒乓感染,收獲高滴度Ad5- HA117重組腺病毒;并用RT-PCR方法驗(yàn)證,HA117基因在重組腺并毒Ad5- HA117感染的HEK293細(xì)胞的表達(dá)情況; 4重組腺病毒Ad5- HA117體外感染K562、Jurkat細(xì)胞,將重組腺病毒Ad5- HA117體外感染K562、Jurkat細(xì)胞,應(yīng)用流式細(xì)胞術(shù)及RT-PCR方法檢測感染后的K562細(xì)胞HA117表達(dá)情況; 5檢測感染重組腺病毒Ad5- HA117使HA117基因高表達(dá)后白血病細(xì)胞耐藥性改變:實(shí)驗(yàn)分四組:K562細(xì)胞組,K562/ Ad5- HA117細(xì)胞組, K562/ Ad5-GFP細(xì)胞組, K562/ Ad5-mdr1細(xì)胞組,Jurkat細(xì)胞分組同K562。通過對細(xì)胞活性、細(xì)胞形態(tài)學(xué)及MTT法抗癌藥物敏感實(shí)驗(yàn),柔紅霉素排泄實(shí)驗(yàn)等檢測HA117基因高表達(dá)前后細(xì)胞形態(tài)及耐藥性的變化,初步研究HA117基因的耐藥功能及耐藥機(jī)制。 結(jié)果 1新基因HA117 mRNA在人體癌旁正常組織和良性腫瘤、惡性腫瘤組織中均有表達(dá),惡性腫瘤組織中表達(dá)陽性率高于良性腫瘤及癌旁正常組織中表達(dá)陽性率(P0.5)。在鱗癌和腺癌中的陽性表達(dá)率分別是16.67%和61.54%,腺癌中的表達(dá)高于鱗癌(P0.05)。有轉(zhuǎn)移的癌組織中HA117 mRNA的表達(dá)率高達(dá)70%,明顯高于非轉(zhuǎn)移型腫瘤組織的20%(P0.05) ; 2首先采用RT-PCR方法驗(yàn)證了HA117基因在腎臟組織中高表達(dá)。HA117基因的3′RACE PCR產(chǎn)物大小在400bp左右, 5′以RACE PCR產(chǎn)物大小在950bp左右,將HA117基因3′RACE序列、5’RACE擴(kuò)增序列與己知的HA117基因序列拼接后,得到1110 bp的全長cDNA序列; 3經(jīng)酶切鑒定成功構(gòu)建腺病毒重組質(zhì)粒Ad5- HA117,重組腺病毒Ad5- HA117成功轉(zhuǎn)染包裝細(xì)胞,在細(xì)胞內(nèi)得到良好的表達(dá),并在包裝細(xì)胞中迅速擴(kuò)增,獲得高滴度的重組腺病毒。收獲的病毒感染液滴度達(dá)1.5×1011pfu/ml;RT-PCR方法證實(shí)外源性HA117基因在感染HEK293細(xì)胞基因組中功能性表達(dá); 4重組腺病毒Ad5-HA117成功將外源性HA117基因?qū)隟562、Jurkat細(xì)胞,轉(zhuǎn)染48小時(shí)后發(fā)現(xiàn)隨著感染復(fù)數(shù)的增加,病毒對K562、Jurkat細(xì)胞的感染率也增加, MOI值為100時(shí)細(xì)胞的存活率和感染率均較好,轉(zhuǎn)染率分別可以達(dá)到39.72%、17.10%;RT-PCR方法證實(shí)外源性HA117基因在轉(zhuǎn)染K562、Jurkat細(xì)胞基因組中功能性表達(dá); 5轉(zhuǎn)染HA117基因的K562、Jurkat細(xì)胞對VCR、AD5M、Vp-16、DNR、MMC、CTX藥物的耐藥性均比低表達(dá)HA117基因未轉(zhuǎn)染的k562、Jurkat細(xì)胞增高,分別增高2~7倍(P0.05或0.01),轉(zhuǎn)染空載體組細(xì)胞耐藥性跟未轉(zhuǎn)染組的k562、Jurkat細(xì)胞相比無顯著差異(P0.05);感染Ad5-HA117組細(xì)胞與感染Ad5-mdr1組相比,耐藥性無顯著差異(P0.05)。轉(zhuǎn)染HA117基因的使其高表達(dá)后的K562、Jurkat細(xì)胞,與轉(zhuǎn)染了MDR1基因的細(xì)胞組柔紅霉素排除實(shí)驗(yàn)結(jié)果顯示,感染Ad5-HA117組細(xì)胞未見有明顯的藥物外排泵功能。 結(jié)論 1初步證實(shí)HA117基因,在人體癌旁正常組織和良性腫瘤、惡性腫瘤組織中均有表達(dá),惡性腫瘤組織中表達(dá)陽性率高于良性腫瘤及癌旁正常組織中表達(dá)陽性率。HA117表達(dá)陽性率可能與惡性腫瘤的組織學(xué)類型及是否為轉(zhuǎn)移瘤有關(guān); 2腎臟組織中高表達(dá)HA117基因,采用RACE法從腎臟組織中成功克隆得到了HA117基因全長cDNA序列,為全長1110bp; 3應(yīng)用分子生物學(xué)方法構(gòu)建了HA117重組腺病毒Ad5- HA117。通過熒光顯微鏡證實(shí),重組腺病毒Ad5- HA117成功轉(zhuǎn)染包裝細(xì)胞,在細(xì)胞內(nèi)得到良好的表達(dá),獲得高滴度的重組腺病毒。證實(shí)外源性HA117基因在感染的HEK293細(xì)胞有效表達(dá); 4通過腺病毒載體可在體外將外源性HA117基因有效的轉(zhuǎn)K562、Jurkat細(xì)胞中,轉(zhuǎn)染的HA117基因能在靶細(xì)胞中表達(dá); 5初步證實(shí)HA117基因具有多藥耐藥功能;其多藥耐藥功能可能不是遵循mdr1經(jīng)典的藥物外排泵機(jī)制。
[Abstract]:objective
The tissue expression profile of HA117 gene was screened by the method of tissue microarray and in situ hybridization. Then the kidney tissue with high expression of HA117 gene screened by tissue expression spectrum was used as a template. The full length cDNA of the gene was cloned through the RACE method, and the recombinant adenovirus mediated K562, Jurkat cell, which expressed the high expression of HA117 gene, was obtained. Objective to study the multidrug resistance (MDR) function of HA117 gene on K562 and Jurkat cells.
Method
1 tissue expression profiles were screened, 31 common tumor tissue specimens embedded in paraffin were selected and 17 cases of normal tissues adjacent to cancer were fabricated. MRNA in situ hybridization was used to detect the expression of HA117 mRNA in tissue microarrays.
2 the results of tissue expression suggest that the kidney tissue is highly expressed HA117 gene, collecting and extracting the total mRNA of kidney tissue. First, RT-PCR method is used to verify the expression of HA117 gene in the kidney tissue, and then the specific primers are designed according to the known sequence of known HA117 genes in the high expression of HA117 gene, and the RACE technical gram is used. The long cDNA sequence of the long HA117 gene;
3 the recombinant adenovirus carrying the full length cDNA sequence of the new gene HA117, the plasmid vector pAdTrack-CMV and the target gene HA117 were constructed, the vector and the target gene were cloned with the T4DNA ligase, and the recombinant plasmid pAdTrack- HA117. containing the target gene HA117 would be screened and identified, and the correct plasmid pAdTrack- HA117 was screened and introduced into the system. In the adenovirus homologous skeleton plasmid BJ-Adeasy, the adenovirus plasmid Adeasy- HA117 was produced, and the recombinant adenovirus plasmid Adeasy- HA117. liposome mediated by the recombinant adenovirus plasmid, Adeasy- HA117 was transfected into the virus packaged cell HEK 293, and the high titer Ad5- HA117 recombinant adenovirus was captured by ping-pong infection; and RT-PCR prescription was used. The expression of HA117 gene in HEK293 cells infected with Ad5- HA117 was detected by the method.
4 recombinant adenovirus Ad5- HA117 infected K562, Jurkat cells in vitro, and the recombinant adenovirus Ad5- HA117 was infected with K562, Jurkat cells in vitro, and the HA117 expression of K562 cells after infection was detected by flow cytometry and RT-PCR methods.
5 detection of recombinant adenovirus Ad5- HA117 to change the drug resistance of leukemia cells after high expression of HA117 gene: the experiment was divided into four groups: K562 cell group, K562/ Ad5- HA117 cell group, K562/ Ad5-GFP cell group, K562/ Ad5-mdr1 cell group, Jurkat cells grouping with cell activity, cell morphology and anti-cancer drug sensitivity experiment, Daunorubicin excretion test was used to detect the changes of cell morphology and drug resistance before and after high expression of HA117 gene, and to preliminarily study the resistance and resistance mechanism of HA117 gene.
Result
1 new gene HA117 mRNA was expressed in normal tissues and benign tumors and in malignant tumor tissues. The positive rate of malignant tumor tissues was higher than that in benign tumor and normal tissue adjacent to cancer (P0.5). The positive expression rate in squamous and adenocarcinoma was 16.67% and 61.54%, respectively, and the expression in adenocarcinoma was higher than that of squamous carcinoma (P0.05). The expression rate of HA117 mRNA in metastatic cancer tissues was 70%, which was significantly higher than that in non metastatic tumor tissues (20%) (P0.05).
2 first, the RT-PCR method was used to verify that the size of the 3 'RACE PCR product of the high expression of the.HA117 gene in the kidney tissue was around 400bp, and the 5' was about 950bp about the size of the RACE PCR product, and the 3 'RACE sequence of the HA117 gene, the 5' RACE amplification sequence was spliced with the known sequence of the genes, and the full length sequence of 1110 was obtained.
3 the recombinant adenovirus recombinant plasmid Ad5- HA117 was successfully constructed by enzyme digestion. The recombinant adenovirus Ad5- HA117 was successfully transfected into the packed cells, and the recombinant adenovirus was successfully expressed in the cells. The recombinant adenovirus was rapidly amplified in the packaging cells and obtained the recombinant adenovirus with high titer. The titer of the harvested virus was 1.5 * 1011pfu/ml, and the RT-PCR method confirmed the exogenous HA117 gene. Functional expression in the genome of infected HEK293 cells;
4 recombinant adenovirus Ad5-HA117 succeeded in introducing exogenous HA117 gene into K562 and Jurkat cells. After 48 hours transfection, the infection rate of K562 and Jurkat cells increased with the increase of complex number of infection. The survival rate and infection rate of the cells were better when the MOI value was 100, and the transfection rate could reach 39.72% and 17.10%, respectively. RT-PCR method proved exogenous. Functional HA117 gene was expressed in K562 and Jurkat cells.
5 the K562 of HA117 gene transfected, the resistance of Jurkat cells to VCR, AD5M, Vp-16, DNR, MMC, and CTX were all higher than that of the low expression HA117 gene. There was no significant difference in the resistance between the cells and the infected Ad5-mdr1 group (P0.05). The transfection of HA117 gene to the high expression of K562, Jurkat cells, and the result of the removal of erythromycin from the cell group transfected with the MDR1 gene showed that there was no obvious drug efflux pump function in the infected Ad5-HA117 group.
conclusion
1 it was preliminarily confirmed that HA117 gene was expressed in normal tissue and benign tumor, and in malignant tumor tissues. The positive rate of expression in malignant tumor tissues was higher than that of benign tumor and normal tissue adjacent to cancer. The positive rate of.HA117 expression may be related to the histological type of malignant tumor and whether it is metastatic tumor.
2 the HA117 gene was highly expressed in renal tissue. The full-length cDNA sequence of HA117 gene was successfully cloned from renal tissue by RACE method, and the full-length 1110bp was obtained.
3 the recombinant adenovirus Ad5- HA117. of HA117 was constructed by the molecular biology method. The recombinant adenovirus Ad5- HA117 was successfully transfected into the packed cell, and the recombinant adenovirus was well expressed in the cell, and the recombinant adenovirus with high titer was obtained. The effective expression of the exogenous HA117 gene in the infected HEK293 cells was confirmed.
4 the exogenous HA117 gene can be effectively transferred into K562 and Jurkat cells by adenovirus vector in vitro. The transfected HA117 gene can be expressed in target cells.
5 it is preliminarily confirmed that HA117 gene has multidrug resistance function, and its multidrug resistance function may not follow the classical drug efflux pump mechanism of MDR1.
【學(xué)位授予單位】：重慶醫(yī)科大學(xué)
【學(xué)位級別】：博士
【學(xué)位授予年份】：2008
【分類號(hào)】：R346

【相似文獻(xiàn)】

相關(guān)會(huì)議論文 前10條

1 曾燕如;黃敏仁;王明庥;;楊樹抗黑斑病相關(guān)基因的cDNA克隆及序列分析[A];中國的遺傳學(xué)研究——中國遺傳學(xué)會(huì)第七次代表大會(huì)暨學(xué)術(shù)討論會(huì)論文摘要匯編[C];2003年

2 韓紅兵;徐署光;連正興;陸泉枝;李寧;;中國人白細(xì)胞介素-12(hIL-12)cDNA克隆及序列分析[A];全國首屆動(dòng)物生物技術(shù)學(xué)術(shù)研討會(huì)論文集[C];2004年

3 富偉能;Li Jia;孫開來;;人白血病K562和CEM/VLB_(100)細(xì)胞Apaf-1 cDNA的類型與表達(dá)的關(guān)系[A];中國的遺傳學(xué)研究——中國遺傳學(xué)會(huì)第七次代表大會(huì)暨學(xué)術(shù)討論會(huì)論文摘要匯編[C];2003年

4 葉建國;陳瑾;左小潘;吉永華;;兩個(gè)新型東亞鉗蝎類α型毒素的cDNA克隆和鑒定[A];中國毒理學(xué)會(huì)生物毒素毒理專業(yè)委員會(huì)第4次、中國生物化學(xué)與分子生物學(xué)會(huì)毒素專業(yè)組第5次學(xué)術(shù)研討會(huì)論文摘要[C];2001年

5 楊惠夷;張利紅;張為民;張揚(yáng);;黃鱔促性腺激素釋放激素受體的cDNA克隆[A];第二屆中國動(dòng)物學(xué)會(huì)比較內(nèi)分泌學(xué)分會(huì)和發(fā)育生物學(xué)分會(huì)聯(lián)合學(xué)術(shù)研討會(huì)論文集[C];2005年

6 付艷平;蘇生昌;彭友良;;稻瘟菌誘導(dǎo)性水稻小GTP結(jié)合蛋白的cDNA克隆[A];中國植物病理學(xué)會(huì)第七屆代表大會(huì)暨學(xué)術(shù)研討會(huì)論文摘要集[C];2002年

7 胡細(xì)連;鐘小燕;吳祥甫;周元聰;莊茂辛;舒雨雁;;江浙蝮蛇毒金屬蛋白酶的cDNA克隆及表達(dá)[A];中國毒理學(xué)會(huì)生物毒素毒理專業(yè)委員會(huì)第4次、中國生物化學(xué)與分子生物學(xué)會(huì)毒素專業(yè)組第5次學(xué)術(shù)研討會(huì)論文摘要[C];2001年

8 楊素霞;范保星;孫敬芬;周平坤;吳德昌;;人DNA修復(fù)基因cDNA克隆及微矩陣分析[A];中國毒理學(xué)會(huì)第三屆全國學(xué)術(shù)會(huì)議論文（摘要）集[C];2001年

9 吳春霞;蘇生昌;彭友良;;稻瘟菌誘導(dǎo)性水稻醛脫氫酶基因cDNA克隆[A];中國植物病理學(xué)會(huì)第七屆代表大會(huì)暨學(xué)術(shù)研討會(huì)論文摘要集[C];2002年

10 張利紅;張為民;陳振業(yè);;黃鱔的雞Ⅱ型促性腺激素釋放激素的cDNA克隆[A];中國生理學(xué)會(huì)肥胖的臨床與基礎(chǔ)暨神經(jīng)免疫內(nèi)分泌學(xué)術(shù)研討會(huì)論文摘要匯編[C];2003年

相關(guān)重要報(bào)紙文章 前4條

1 謝建平 執(zhí)筆;以促進(jìn)人類科技創(chuàng)新為準(zhǔn)繩[N];醫(yī)藥經(jīng)濟(jì)報(bào);2001年

2 佚名;詮釋環(huán)境與人的“親密”關(guān)系[N];醫(yī)藥經(jīng)濟(jì)報(bào);2001年

3 記者 曹繼軍 通訊員 趙如江;我科學(xué)家首次發(fā)現(xiàn)附睪中一種抗菌肽基因[N];光明日報(bào);2001年

4 東娜;安捷倫推出第三套基因篩選微陣列試劑盒[N];科技日報(bào);2002年

相關(guān)博士學(xué)位論文 前10條

1 郭玉霞;新基因HA117全長cDNA克隆及其耐藥功能的實(shí)驗(yàn)研究[D];重慶醫(yī)科大學(xué);2008年

2 李華;嗜熱毛殼菌（Chaetomium thermophilium）熱穩(wěn)定性β-1，，3-葡聚糖酶的純化特性及cDNA克隆[D];山東農(nóng)業(yè)大學(xué);2008年

3 王驥;福壽螺（Ampullaria crossean）多功能纖維素酶EGX的研究[D];中國科學(xué)院研究生院（上海生命科學(xué)研究院）;2004年

4 許守明;小鹽芥C_2H_2類鋅指蛋白基因ThZF1的克隆及其功能研究[D];中國農(nóng)業(yè)大學(xué);2005年

5 張付云;殼寡糖誘導(dǎo)煙草抗性相關(guān)基因的克隆和鑒定[D];中國科學(xué)院研究生院（大連化學(xué)物理研究所）;2007年

6 童斌;柿果實(shí)擴(kuò)張蛋白cDNA克隆及其生物活性研究[D];西北農(nóng)林科技大學(xué);2003年

7 朱玲;扇貝絲氨酸蛋白酶及其抑制劑基因的克隆與表達(dá)[D];中國科學(xué)院研究生院（海洋研究所）;2006年

8 劉衛(wèi)霞;人鈣周期素結(jié)合蛋白（CacyBP）基因的克隆和功能研究[D];中國協(xié)和醫(yī)科大學(xué);2002年

9 陳靜;嗜熱毛殼菌熱穩(wěn)定糖化酶純化及其編碼基因的克隆與表達(dá)[D];山東農(nóng)業(yè)大學(xué);2006年

10 孫迅;粗毛栓菌的木質(zhì)纖維素降解酶及其基因克隆[D];四川大學(xué);2005年

相關(guān)碩士學(xué)位論文 前10條

1 王姝雅;陰道毛滴蟲病毒基因組全長cDNA克隆[D];吉林大學(xué);2006年

2 朱景全;家蠅金屬硫蛋白的cDNA克隆與序列測定[D];華中農(nóng)業(yè)大學(xué);2003年

3 馬云芳;斑馬魚（Danio rerio）P-糖蛋白cDNA的克隆及表達(dá)分析[D];西南大學(xué);2008年

4 宋寧寧;嗜熱子囊菌光孢變種超氧化物歧化酶（Mn-SOD）基因的克隆、表達(dá)及性質(zhì)研究[D];山東農(nóng)業(yè)大學(xué);2009年

5 張佳;疏綿狀嗜熱絲孢菌超氧化物歧化酶（Mn-SOD）基因的克隆和表達(dá)及性質(zhì)研究[D];山東農(nóng)業(yè)大學(xué);2009年

6 張廣操;耐熱大豆β-淀粉酶的篩選及其cDNA在大腸桿菌中的表達(dá)[D];中國農(nóng)業(yè)科學(xué)院;2005年

7 尹志亮;絹絲昆蟲柳蠶卵黃原蛋白（Vg）cDNA的克隆及序列分析[D];安徽農(nóng)業(yè)大學(xué);2007年

8 鄭艷;疏棉狀嗜熱絲孢菌熱穩(wěn)定脂肪酶的基因克隆與表達(dá)[D];山東農(nóng)業(yè)大學(xué);2008年

9 李小園;橡膠樹膠乳中膜結(jié)合型焦磷酸酶基因的克隆和表達(dá)研究[D];華南熱帶農(nóng)業(yè)大學(xué);2005年

10 劉維青;海灣扇貝金屬硫蛋白cDNA序列克隆及其在鎘和鰻弧菌誘導(dǎo)下的表達(dá)研究[D];中國海洋大學(xué);2005年

本文編號(hào)：1963708